| |
Learning Center
Hemostasis Happenings
Monday, December 1, 2008
Hemostasis Happenings: December 2008
Friday December 5th: Satelleite Symposium: San Francisco, Moscone Center
Thromboembolism in Cancer Patients: A Cogent Approach to Risk Assessment, Prevention, and Treatment 12;30--4:30PM
Speakers:
Gary H. Lyman, MD, Duke University Medical Center, Duke Comprehensive Cancer Center, Duke Center for Clinical Health Policy Research, Durham, NC
Alok A. Khorana, MD, James P. Wilmot Cancer Center, University of Rochester, Rochester, NY
Michael M. Millenson, MD, Fox Chase Cancer Center, Philadelphia, PA
New Perspectives, New Strategies in Venous Thromboembolic Disease 6-10PM
Speakers:
Jeffrey Weitz, MD, Henderson Research Centre, McMaster University, Hamilton, Ontario, Canada
Charles T. Esmon, PhD, University of Oklahoma Health Sciences Center, Oklahoma City, OK
Alexander G.G. Turpie, MD, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
Richard Joel Friedman, MD, Charleston Orthopaedic Associates, Charleston, SC
ASH 50th Anniversary Meeting- San Francisco, California
Saturday Dec 6th:
Scientific Committee on Hemostasis
Hemostasis and Cancer
Chair:
David Lillicrap, MD, Queen's University, Kingston, Ontario, Canada
Speakers:
Ajit P. Varki, MD, University of California School of Medicine, La Jolla, CASelectins, Heparins, and Cancer: Rationale for Clinical Trials
Jerry Ware, PhD, University of Arkansas for Medical Sciences, Little Rock, ARPlatelet Glycoprotein 1b-1X in Hemostasis and Malignancy
Joseph Palumbo, MD, Cincinnati Children's Hospital Medical Center and The University of Cincinnati College of Medicine, Cincinnati, OH Mechanisms Coupling Thrombin-Mediated Proteolysis to Metastasis
Scientific Committee on Platelets
Platelet Life Cycle
Chair:
Kenneth J. Clemetson, PhD, DSc, Theodor Kocher Institute, University of Berne, Berne, Switzerland
Speakers:
Alan B. Cantor, MD, PhD, Children's Hospital Boston, Boston, MATranscriptional Regulation of Thrombopoiesis
Elisabeth Cramer-Bordé, PhD, Hôpital Ambroise Paré, Boulogne, FrancePlatelet Birth
Benajmin T. Kile, PhD, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Platelet Death
Scientific Commitee on Thrombosis and Vascular Biology
Crosstalk Between Vascular Inflammation and Thrombosis
Chair:
Wolfram Ruf, MD, The Scripps Research Institute, La Jolla, CA
Speakers:
Paul S. Frenette, MD, Mount Sinai School of Medicine, New York, NY, Contributions of Immune Cells to Vascular Occlusion in Sickle Cell Disease
Andrew S. Weyrich, PhD, University of Utah, Salt Lake City, UT Novel Mechanisms of Translational Control Linking Inflammation and Thrombosis
J. Evan Sadler, MD, PhD, Washington University Medical School, St. Louis, MOVon Willebrand Factor in Weibel-Palade Bodies
Thrombophilia and Thrombosis in Children
Chair:
Marilyn J. Manco-Johnson, MD, University of Colorado, Denver, CO
Speakers:
Leslie Raffini, MD, Children's Hospital of Philadelphia, Philadelphia, PA Thrombophilia in Children: Who to Test, How, When, and Why
Neil Goldenberg, MD, Mountain States Regional Hemophilia and Thrombosis Center and The Children's Hospital, University of Colorado, Aurora, CO, Genetic and Acquired Thrombophilias in Children: Outcome Predictors
Guy Young, MD, Children's Hospital Los Angeles, Los Angeles, CA, New Anticoagulants in Children: Pharmacokinetics, Pharmocodynamics, Risks, and Benefits
Thrombosis
Chair:
Charles W. Francis, MD, University of Rochester Medical Center, Rochester, NY
Speakers:
Henri Bounameaux, MD, University Hospital of Geneva, Geneva, Switzerland. Duration of Anticoagulation Therapy for Venous Thromboembolism
Charles W. Francis, MD, University of Rochester Medical Center, Rochester, NY. New Issues in Oral Anticoagulants
Mark A. Crowther, MD, St. Joseph's Hospital and McMaster University, Hamilton, Ontario, Canada. Reversal of Coumadin Over-Anticoagulation
Tuesday, December 9
Special Symposium on the Basic Science of Hemostasis and ThrombosisPresented by the Scientific Committees on Hemostasis, Vascular Biology, and Platelets
Invited presentations:
Tuesday, December 9, 7:30 a.m. - 9:00 a.m.
Simultaneous oral sessions:
Tuesday, December 9, 1:00 p.m. - 2:30 p.m.
Co-Chairs:
Nigel S. Key, MD, University of North Carolina, Chapel Hill, NC
Eric F. Grabowski, MD, ScD, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Elizabeth Cramer-Bordé, PhD, Hopital Ambroise Pare, Boulogne, France
Speakers:
Paul Kubes, PhD, University of Calgary, Calgary, Alberta, Canada. Platelet Toll-Like Receptors in Hemostasis and Host Defense
Scott L. Diamond, PhD, University of Pennsylvania, Philadelphia, PA. Flow Initiation of Thrombosis
Leslie V. Parise, PhD, University of North Carolina, Chapel Hill, NC. Platelet Activation and Inflammation
Berend Isermann, MD, University of Heidelberg, Heidelberg, Germany. The Thrombomodulin-Protein C System and Angiopathy
Speaker To Be Determined. A presentation will be made by the 2008 recipient of the Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis, the trainee with the highest-scoring abstract at the ASH annual meeting in the field of hemostasis and thrombosis.
Donna Castellone
|
|
About the Author
Donna Castellone,
MS, MT(ASCP)SH
View Complete Profile
Links
Previous Posts
Archives
|
|
